PolypAID™ Platform
Colorectal polyp detection during colonoscopy screening
Pre-clinicalActive
Key Facts
Indication
Colorectal polyp detection during colonoscopy screening
Phase
Pre-clinical
Status
Active
Company
About Augere Medical
Augere Medical is a private, clinical-stage medical device and digital health company focused on transforming colorectal cancer screening with its AI platform, PolypAID™. The company has raised NOK 73 million (approx. USD 6.6M) from a mix of public grants and private investors, including AM Equity and MP Pensjon, and is advancing its platform through clinical validation and regulatory pathways. With a strong foundation in research from Simula and leading Scandinavian hospitals, Augere aims to reduce missed polyps and interval cancers by providing real-time, high-accuracy decision support to gastroenterologists.
View full company profile